{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:37:30Z","timestamp":1790779050422,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several mechanisms, including altered local and systemic immune system, apoptosis, and new angiogenesis, are responsible for the development and progression of endometriosis. Over the years many markers have been studied, like CA 125 and, recently, neutrophil-to-lymphocyte ratio (NLR). This tool is cost-effectiveness and non-invasiveness as a marker of systemic inflammatory diseases. The aim of this study is to assess the role of NLR in the real-life management of patients with endometriosis in order to evaluate the possible association between this value and symptoms. We performed a retrospective analysis of 199 premenopausal women affected by endometriosis, from January 2013 to December 2020, evaluating the characteristics of disease, the symptoms and the NLR. Analyzing the neutrophiles, the mean\u2009\u00b1\u2009SD value was 6.1\u2009\u00b1\u20094.5\u2009\u00d7\u200910<jats:sup>3<\/jats:sup>\/ul, while for lymphocytes mean\u2009\u00b1\u2009SD value was 1.8\u2009\u00b1\u20090.7.NLR was categorized according to its median value (&gt;\u20092.62 vs\u2009\u2264\u20092.62). The comparison between NLR values and CA 125, endometriosis stage, dysmenorrhea and presence of chronic pelvic pain, adjusting for previous therapy did not find a significant association. An interesting result, although not significant, was the association between NLR and chronic pelvic pain (OR\u2009=\u20091.9). In the sub-group of patients without previous therapy this association is even stronger (OR\u2009=\u20094.8, 95% CI 0.5\u201350.2, p\u2009=\u20090.190). The link between NLR and chronic pelvic pain can provide a further hint to the clinician even when taking symptoms into account to develop a particular therapeutic treatment related to the various expressions of NLR. Finally, NLR may enable the creation of customized follow-up protocols that divide patients into high- and low-risk categories for endometriosis recurrence.<\/jats:p>","DOI":"10.1038\/s41598-024-58115-6","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:02:36Z","timestamp":1711810956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neutrophil to lymphocytes ratio in deep infiltrating endometriosis as a new toll for clinical management"],"prefix":"10.1038","volume":"14","author":[{"given":"Mattia","family":"Dominoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna Francesca","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Musacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"De Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Valeria","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"key":"58115_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijgo.2010.03.039","volume":"110","author":"S Ferrero","year":"2010","unstructured":"Ferrero, S. et al. Prevalence of newly diagnosed endometriosis in women attending the general practitioner. Int. J. Gynaecol. Obstet. 110, 203\u2013207 (2010).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"58115_CR2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00404-012-2473-5","volume":"286","author":"M Morotti","year":"2012","unstructured":"Morotti, M. et al. Endometriosis in menopause: A single institution experience. Arch. Gynecol. Obstet. 286, 1571\u20131575 (2012).","journal-title":"Arch. Gynecol. Obstet."},{"key":"58115_CR3","first-page":"68","volume":"111","author":"VL La Rosa","year":"2020","unstructured":"La Rosa, V. L. et al. Quality of life in women with endometriosis: A narrative overview. Minerva Med. 111, 68\u201378 (2020).","journal-title":"Minerva Med."},{"key":"58115_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","volume":"10","author":"P Vercellini","year":"2014","unstructured":"Vercellini, P. et al. Endometriosis: Pathogenesis and treatment. Nat. Rev. Endocrinol. 10, 261\u2013275 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"58115_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2741\/4431","volume":"21","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Inflammation and endometriosis. Front. Biosci. (Landmark Ed.) 21, 941\u20138 (2016).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"58115_CR6","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1038\/s41598-022-07349-3","volume":"12","author":"B Gardella","year":"2022","unstructured":"Gardella, B. et al. Endometriosis pain and epithelial neutrophil activating peptide-78 levels. Sci. Rep. 12, 3227 (2022).","journal-title":"Sci. Rep."},{"key":"58115_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/13543784.2019.1618269","volume":"28","author":"F Barra","year":"2019","unstructured":"Barra, F. et al. Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis. Expert. Opin. Investig. Drugs 28, 501\u2013504 (2019).","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"58115_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/humrep\/17.2.426","volume":"17","author":"MA Bedaiwy","year":"2002","unstructured":"Bedaiwy, M. A. et al. Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum. Reprod. 17, 426\u2013431 (2002).","journal-title":"Hum. Reprod."},{"key":"58115_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1600-0897.2007.00535.x","volume":"58","author":"SH Cho","year":"2007","unstructured":"Cho, S. H. et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am. J. Reprod. Immunol. 58, 497\u2013504 (2007).","journal-title":"Am. J. Reprod. Immunol."},{"key":"58115_CR10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/humrep\/deg321","volume":"18","author":"E Darai","year":"2003","unstructured":"Darai, E. et al. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum. Reprod. 18, 1681\u20131685 (2003).","journal-title":"Hum. Reprod."},{"key":"58115_CR11","first-page":"99","volume":"81","author":"A O\u2019Shaughnessy","year":"1993","unstructured":"O\u2019Shaughnessy, A. et al. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis. Obstet. Gynecol. 81, 99\u2013103 (1993).","journal-title":"Obstet. Gynecol."},{"key":"58115_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/oxfordjournals.humrep.a136064","volume":"10","author":"MD Hornstein","year":"1995","unstructured":"Hornstein, M. D. et al. Use of a new CA 125 assay in the diagnosis of endometriosis. Hum. Reprod. 10, 932\u2013934 (1995).","journal-title":"Hum. Reprod."},{"key":"58115_CR13","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0015-0282(98)00355-0","volume":"70","author":"BW Mol","year":"1998","unstructured":"Mol, B. W. et al. The performance of CA 125 measurement in the detection of endometriosis: A meta-analysis. Fertil. Steril. 70, 1101\u20131108 (1998).","journal-title":"Fertil. Steril."},{"key":"58115_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1164\/ajrccm.159.3.9805087","volume":"159","author":"B Jilma","year":"1999","unstructured":"Jilma, B. et al. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am. J. Respir. Crit. Care Med. 159, 857\u201363 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5\u201314","key":"58115_CR15","first-page":"18","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec, R. Ratio of neutrophil to lymphocyte counts: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy. 102(5\u201314), 18 (2001).","journal-title":"Bratisl. Lek. Listy."},{"key":"58115_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejogrb.2007.05.012","volume":"138","author":"S Bishara","year":"2008","unstructured":"Bishara, S. et al. Pretreatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 138, 71\u201375 (2008).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"58115_CR17","first-page":"5","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec, R. Ratio of neutrophil to lymphocyte counts\u2014rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy. 102, 5\u201314 (2001).","journal-title":"Bratisl. Lek. Listy."},{"key":"58115_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3760\/cma.j.issn.0366-6999.20123569","volume":"126","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA 125 for stages III and IV endometriosis. Chin. Med. J. (Engl.) 126, 2011\u20134 (2013).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"58115_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0015-0282(97)81391-X","volume":"67","author":"American Society for Reproductive Medicine","year":"1997","unstructured":"American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril. 67, 817\u2013821 (1997).","journal-title":"Fertil. Steril."},{"key":"58115_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/01443615.2020.1845634","volume":"41","author":"A Moini","year":"2021","unstructured":"Moini, A. et al. Evaluating hematological parameters in women with endometriosis. J. Obstet. Gynaecol. (Lahore) 41, 1151\u20136 (2021).","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"key":"58115_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0015-0282(98)00355-0","volume":"70","author":"BWJ Mol","year":"1998","unstructured":"Mol, B. W. J. et al. The performance of CA 125 measurement in the detection of endometriosis: A meta-analysis. Fertil. Steril. 70, 1101\u20131108 (1998).","journal-title":"Fertil. Steril."},{"key":"58115_CR22","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.fertnstert.2008.03.061","volume":"90","author":"S Cho","year":"2008","unstructured":"Cho, S. et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA 125 for the diagnosis of endometriosis. Ferti. Steril. 90, 2073\u20132079 (2008).","journal-title":"Ferti. Steril."},{"key":"58115_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5152\/jtgga.2013.55452","volume":"14","author":"A Yavuzcan","year":"2013","unstructured":"Yavuzcan, A. et al. Evaluation of mean platelet volume, neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio in advanced stage endometriosis with endometrioma. J. Turk. Ger. Gynecol. Assoc. 14, 210\u2013215 (2013).","journal-title":"J. Turk. Ger. Gynecol. Assoc."},{"key":"58115_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5653\/cerm.2014.41.4.151","volume":"41","author":"SK Kim","year":"2014","unstructured":"Kim, S. K., Park, J. Y., Jee, B. C., Suh, C. S. & Kim, S. H. Association of the neutrophil-to- lymphocyte ratio and CA 125 with the endometriosis score. Clin. Exp. Reprod. Med. 41, 151 (2014).","journal-title":"Clin. Exp. Reprod. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58115-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:05:37Z","timestamp":1711811137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58115-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["58115"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-58115-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7575"}}